Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHargreaves Lansdown Regulatory News (HL.)

Share Price Information for Hargreaves Lansdown (HL.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 824.80
Bid: 826.00
Ask: 826.60
Change: 12.80 (1.58%)
Spread: 0.60 (0.073%)
Open: 824.00
High: 835.60
Low: 822.40
Prev. Close: 812.00
HL. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

4 Mar 2016 14:30

RNS Number : 1356R
Hargreaves Lansdown PLC
04 March 2016
 

 

Hargreaves Lansdown plc

DIRECTOR/PDMR SHAREHOLDING - GRANT OF AWARDS

4th March 2016

On 3rd March 2016, Christopher Hill, Chief Financial Officer, was granted the following options over Hargreaves Lansdown PLC Ordinary Shares.

 

Number of Shares subject to option

Option Price

 

Vesting date

Arrangement

27,100

Nil cost

4th August 2016

Listing Rule 9.4.2 arrangement

 

12,200

Nil cost

4th August 2017

Listing Rule 9.4.2 arrangement

50,000

£12.56

3rd March 2019

Unapproved Share Option Plan 2012

 

The nil-cost options will become exercisable on vesting dates shown above, subject to continuous employment with the Hargreaves Lansdown plc.

 

Buy-Out Awards

 

The nil-cost options were awarded to Mr Hill under an arrangement to which Listing Rule 9.4.2 applies in respect of the buy-out of the share option arrangements Mr Hill forfeited on leaving his previous employment. This was previously disclosed in the Directors' Remuneration Report of the Hargreaves Lansdown PLC Annual Report and Financial Statements 2015. 

 

The Remuneration Committee believes that the award fairly reflects the value of awards Mr Hill forfeited on leaving his previous employment in terms of value and timescale of vesting.

LTIP

Mr Hill was also conditionally awarded Hargreaves Lansdown PLC Ordinary shares under the Hargreaves Lansdown Unapproved Share Option Plan 2012 ("the LTIP"). The award was made in line with that made to other Directors/ PDMRs in October 2015, with the number of awards made adjusted for the shorter period of time Mr Hill is employed during the performance period.

 

The awards have an exercise price of £12.56 per share and will vest (in proportion that the performance criteria have been achieved) no sooner than three years from the date of grant, or on the date on which the Remuneration Committee determine the performance conditions have been met, which shall be no later than three months following the approval of the accounts for year ended 30 June 2018, whichever is later.

 

The options may then be exercised at the Mr Hill's discretion until 3rd March 2022 (being the 6th anniversary of the date of grant of the award). To the extent the performance conditions are not met, the options shall lapse.

 

 Further details relating to the operation of the LTIP can be found within the Annual Report and Accounts available on the Company's website.

 

This announcement is made in accordance with the requirements of DTR 3.1.4.

 

For further information please contact:

 Hargreaves Lansdown +44 (0) 117 9809989

Judy Matthews, Company Secretary

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSXZLFBQXFXBBK
Date   Source Headline
1st May 20249:27 amRNSDirector Declaration
30th Apr 20247:00 amRNSTrading Statement
25th Apr 20242:43 pmRNSDirector Declaration
19th Apr 20241:56 pmRNSDirector/PDMR Shareholding
4th Apr 202411:24 amRNSDirector/PDMR Shareholding
7th Mar 20241:54 pmRNSDirector/PDMR Shareholding
28th Feb 20244:01 pmRNSDirector/PDMR Shareholding
27th Feb 20242:29 pmRNSDirector/PDMR Shareholding
26th Feb 20244:43 pmRNSDirector/PDMR Shareholding
23rd Feb 20244:05 pmRNSDirector/PDMR Shareholding
22nd Feb 20247:00 amRNSHalf-year Report
9th Feb 202412:10 pmRNSNotice of Results
6th Feb 202412:08 pmRNSDirectorate Change
1st Feb 20247:09 amRNSDirector Declaration
17th Jan 202412:03 pmRNSDirector Declaration
2nd Jan 202410:06 amRNSDirector Declaration
20th Dec 202312:50 pmRNSDirector/PDMR Shareholding
14th Dec 202312:06 pmRNSDirector Declaration
11th Dec 20237:17 amRNSDirector Declaration
8th Dec 20234:33 pmRNSResult of AGM
6th Dec 20238:10 amRNSDirector Declaration
29th Nov 20237:00 amRNSDirectorate Change
7th Nov 20231:54 pmRNSNotice of AGM
23rd Oct 20238:00 amRNSAnnual Financial Report
19th Oct 20237:00 amRNSTrading Statement
12th Oct 20234:10 pmRNSDirector/PDMR Shareholding
12th Oct 20234:09 pmRNSDirector/PDMR Shareholding
22nd Sep 20233:21 pmRNSDirector/PDMR Shareholding
21st Sep 20234:15 pmRNSDirector/PDMR Shareholding
19th Sep 20237:00 amRNSFinal Results
1st Sep 20239:59 amRNSNotice of Results
19th Jul 20237:00 amRNSTrading Statement
17th Jul 20234:32 pmRNSDirectorate Change
10th Jul 202311:00 amRNSDirectorate Change
15th Jun 202312:13 pmRNSHolding(s) in Company
13th Jun 20231:00 pmRNSDirectorate Change
15th May 20234:51 pmRNSDirector/PDMR Shareholding
10th May 20234:01 pmRNSDirector/PDMR Shareholding
4th May 202311:00 amRNSDirector Declaration
4th May 20237:00 amRNSTrading Statement
25th Apr 20232:13 pmRNSDirector/PDMR Shareholding
1st Mar 202310:22 amRNSDirector/PDMR Shareholding
15th Feb 20237:00 amRNSHalf-year Report
27th Jan 202312:02 pmRNSDirector Declaration
23rd Jan 202310:10 amRNSNotice of Results
19th Jan 20233:33 pmRNSHolding(s) in Company
20th Dec 20222:01 pmRNSDirector/PDMR Shareholding
16th Dec 202211:05 amRNSDirector Declaration
8th Dec 20228:00 amRNSDirectorate Change
24th Oct 20223:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.